levonorgestrel and Signs and Symptoms

Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Injections; Intrauterine Devices; Lactation; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Norethindrone; Physiology; Pregnancy; Progesterone; Progestins; Reproduction; Signs and Symptoms

Topics: Asia; Asia, Southeastern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Malaysia; Menstruation Disturbances; Metrorrhagia; Norethindrone; Patient Acceptance of Health Care; Physiology; Research; Sampling Studies; Signs and Symptoms; Statistics as Topic

Topics: Biology; Birth Rate; Breast; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Developed Countries; Digestive System; Disease; Embryo Implantation; Embryonic Development; Endocrine System; Ethics; Ethinyl Estradiol; Europe; Family Planning Services; Fertility; Hormones; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Nausea; Netherlands; Parity; Pelvic Inflammatory Disease; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy, Ectopic; Reproduction; Signs and Symptoms; Vomiting

Topics: Americas; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Developing Countries; Endocrine System; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproductive Control Agents; Sexual Behavior; Signs and Symptoms; United States

Topics: Asia; Asia, Eastern; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Developed Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Japan; Legislation as Topic; Levonorgestrel; Licensure; Risk Assessment; Signs and Symptoms

Topics: Americas; Biology; Blood; Blood Pressure; Body Weight; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developing Countries; Diagnosis; Disease; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Latin America; Levonorgestrel; Lipids; Menstrual Cycle; Menstruation; Metrorrhagia; Mexico; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Signs and Symptoms

Topics: Ambulatory Care Facilities; Biology; Cervix Mucus; Cervix Uteri; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Disease; Family Planning Services; Genitalia; Genitalia, Female; Health Planning; Hemorrhage; Infections; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Organization and Administration; Physiology; Reproduction; Sexually Transmitted Diseases; Signs and Symptoms; Urogenital System; Uterus

Topics: Behavior; Central Nervous System; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Digestive System; Disease; Family Planning Services; Hemorrhage; Levonorgestrel; Libido; Megestrol Acetate; Metrorrhagia; Nausea; Research; Sexual Behavior; Signs and Symptoms

Topics: Age Factors; Amenorrhea; Americas; Anthropometry; Behavior; Biology; Body Weight; Colombia; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developed Countries; Developing Countries; Diagnosis; Disease; Dysmenorrhea; Educational Status; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Fertility; Headache; Hemorrhage; Hormones; Incidence; Latin America; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Neurologic Manifestations; Parity; Patient Acceptance of Health Care; Physiology; Population; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Research; Research Design; Sexual Behavior; Signs and Symptoms; South America; Statistics as Topic

Topics: Aftercare; Asia; Asia, Southeastern; Birth Rate; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developing Countries; Disease; Family Planning Services; Fertility; Hemorrhage; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Population; Population Dynamics; Postpartum Period; Pregnancy Rate; Prospective Studies; Reproduction; Research; Signs and Symptoms; Singapore; Therapeutics; Time Factors